These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 31068182)

  • 1. Association of platelet count with all-cause mortality and risk of cardiovascular and respiratory morbidity in stable COPD.
    Fawzy A; Anderson JA; Cowans NJ; Crim C; Wise R; Yates JC; Hansel NN
    Respir Res; 2019 May; 20(1):86. PubMed ID: 31068182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial.
    Kunisaki KM; Dransfield MT; Anderson JA; Brook RD; Calverley PMA; Celli BR; Crim C; Hartley BF; Martinez FJ; Newby DE; Pragman AA; Vestbo J; Yates JC; Niewoehner DE;
    Am J Respir Crit Care Med; 2018 Jul; 198(1):51-57. PubMed ID: 29442524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts.
    Fawzy A; Putcha N; Paulin LM; Aaron CP; Labaki WW; Han MK; Wise RA; Kanner RE; Bowler RP; Barr RG; Hansel NN;
    Respir Res; 2018 Jan; 19(1):20. PubMed ID: 29373977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet Indices and Risk of Death and Cardiovascular Events: Results from a Large Population-Based Cohort Study.
    Patti G; Di Martino G; Ricci F; Renda G; Gallina S; Hamrefors V; Melander O; Sutton R; Engström G; De Caterina R; Fedorowski A
    Thromb Haemost; 2019 Nov; 119(11):1773-1784. PubMed ID: 31430798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low testosterone levels predict all-cause mortality and cardiovascular events in women: a prospective cohort study in German primary care patients.
    Sievers C; Klotsche J; Pieper L; Schneider HJ; März W; Wittchen HU; Stalla GK; Mantzoros C
    Eur J Endocrinol; 2010 Oct; 163(4):699-708. PubMed ID: 20685832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
    Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
    Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk factors analysis for one-year and long-term mortality in patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease].
    Zhang Y; Lin YX
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Dec; 42(12):895-900. PubMed ID: 31826532
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk.
    Brook RD; Anderson JA; Calverley PM; Celli BR; Crim C; Denvir MA; Magder S; Martinez FJ; Rajagopalan S; Vestbo J; Yates J; Newby DE;
    Heart; 2017 Oct; 103(19):1536-1542. PubMed ID: 28416587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study.
    Daniels K; Lanes S; Tave A; Pollack MF; Mannino DM; Criner G; Neikirk A; Rhodes K; Feigler N; Nordon C
    Int J Chron Obstruct Pulmon Dis; 2024; 19():225-241. PubMed ID: 38259591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum chloride level with mortality and cardiovascular events in chronic kidney disease: the CKD-ROUTE study.
    Mandai S; Kanda E; Iimori S; Naito S; Noda Y; Kikuchi H; Akazawa M; Oi K; Toda T; Sohara E; Okado T; Sasaki S; Rai T; Uchida S
    Clin Exp Nephrol; 2017 Feb; 21(1):104-111. PubMed ID: 27039905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet count is associated with cardiovascular disease, cancer and mortality: A population-based cohort study.
    Vinholt PJ; Hvas AM; Frederiksen H; Bathum L; Jørgensen MK; Nybo M
    Thromb Res; 2016 Dec; 148():136-142. PubMed ID: 27586589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic indicators for in-hospital mortality in COPD with acute exacerbation in Thailand: a retrospective cohort study.
    Morasert T; Jantarapootirat M; Phinyo P; Patumanond J
    BMJ Open Respir Res; 2020 May; 7(1):. PubMed ID: 32467292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy?
    Harrison MT; Short P; Williamson PA; Singanayagam A; Chalmers JD; Schembri S
    Thorax; 2014 Jul; 69(7):609-15. PubMed ID: 24743560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD.
    Hu G; Wu Y; Zhou Y; Wu Z; Wei L; Li Y; Peng G; Liang W; Ran P
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2729-2736. PubMed ID: 27843309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease.
    Man SF; Connett JE; Anthonisen NR; Wise RA; Tashkin DP; Sin DD
    Thorax; 2006 Oct; 61(10):849-53. PubMed ID: 16738034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Blocker Therapy and Clinical Outcomes in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk. An Observational Substudy of SUMMIT.
    Dransfield MT; McAllister DA; Anderson JA; Brook RD; Calverley PMA; Celli BR; Crim C; Gallot N; Martinez FJ; Scanlon PD; Yates J; Vestbo J; Newby DE;
    Ann Am Thorac Soc; 2018 May; 15(5):608-614. PubMed ID: 29406772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic obstructive pulmonary disease and cardiovascular mortality in elderly subjects from general population.
    Mazza A; Zamboni S; Rubello D; Schiavon L; Zorzan S; Casiglia E
    Blood Press; 2010 Apr; 19(2):67-74. PubMed ID: 20001393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study.
    Raparelli V; Pastori D; Pignataro SF; Vestri AR; Pignatelli P; Cangemi R; Proietti M; Davì G; Hiatt WR; Lip GYH; Corazza GR; Perticone F; Violi F; Basili S;
    Intern Emerg Med; 2018 Aug; 13(5):651-660. PubMed ID: 29582316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet activation and cardiovascular comorbidities in patients with chronic obstructive pulmonary disease.
    Malerba M; Olivini A; Radaeli A; Ricciardolo FL; Clini E
    Curr Med Res Opin; 2016 May; 32(5):885-91. PubMed ID: 26824631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands.
    Swart KMA; Baak BN; Lemmens L; Penning-van Beest FJA; Bengtsson C; Lobier M; Hoti F; Vojinovic D; van Burk L; Rhodes K; Garbe E; Herings RMC; Nordon C; Simons SO
    Respir Res; 2023 Nov; 24(1):293. PubMed ID: 37990197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.